Hematopoietic Stem Cell TransplantationTransplantation, AutologousPeripheral Blood Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationBone Marrow TransplantationBone MarrowTransplantation ConditioningBone Marrow CellsStem CellsGraft SurvivalHematopoietic Stem Cell MobilizationMultiple MyelomaGraft vs Host DiseaseCyclophosphamideCombined Modality TherapyAntigens, CD34Hematopoietic Stem CellsBone and BonesTreatment OutcomeGranulocyte Colony-Stimulating FactorAntineoplastic Combined Chemotherapy ProtocolsEtoposideHematologic NeoplasmsLiver TransplantationTransplantation ChimeraMesenchymal Stem Cell TransplantationTissue DonorsCord Blood Stem Cell TransplantationWhole-Body IrradiationCell TransplantationCell DifferentiationBusulfanKidney TransplantationEmbryonic Stem CellsMyeloablative AgonistsHistocompatibility TestingBone Marrow DiseasesRecurrenceAdult Stem CellsLeukemiaRemission InductionHematopoiesisTime FactorsHistocompatibilityRetrospective StudiesMelphalanImmunosuppressive AgentsBone RemodelingBone Marrow ExaminationBone Marrow PurgingCells, CulturedLeukemia, Myeloid, AcuteMesenchymal Stromal CellsMice, Inbred C57BLGraft vs Leukemia EffectBone Marrow NeoplasmsTransplantation ImmunologyFlow CytometryStem Cell NicheSurvival AnalysisHeart TransplantationDisease-Free SurvivalSurvival RatePluripotent Stem CellsAnemia, AplasticMyelodysplastic SyndromesGraft RejectionTransplantation, IsogeneicVidarabineHematologic DiseasesHepatic Veno-Occlusive DiseaseCell LineageLung TransplantationNeural Stem CellsT-LymphocytesChimerismLymphoma, Non-HodgkinColony-Forming Units AssayBone DensityPrecursor Cell Lymphoblastic Leukemia-LymphomaSalvage TherapyLymphocyte TransfusionHLA AntigensFollow-Up StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Tumor EffectMultipotent Stem CellsOrgan TransplantationCell SeparationImmunosuppressionLymphocyte DepletionInduced Pluripotent Stem CellsStem Cell FactorSiblingsAcute DiseasePrognosisCytarabineBone ResorptionCytomegalovirus Infections